Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
Thrombosis Research. Supplement|January 1, 1991
Involvement of the extrinsic pathway in the activities of low molecular weight heparinsL Norrheim, U Abildgaard, M L Larsen, et al.Thrombosis Research. Supplement|January 1, 1991
Anti Xa activity and prothrombinase inhibition in patients treated with two different doses of enoxaparin in gynecologic surgeryM M Samama, S Combe, M H Horellou, et al.Thrombosis Research. Supplement|January 1, 1990
Does low-dose aspirin prevent aortocoronary vein bypass graft occlusion? The Spanish Group for Aortocoronary Bypass Follow-up (GESIC Study)G SanzThrombosis Research. Supplement|January 1, 1990
Prevention of acute complications after percutaneous transluminal coronary angioplastyM G Bourassa, L Schwartz, J Lespérance, et al.Thrombosis Research. Supplement|January 1, 1990
Dipyridamole for coronary artery bypass surgeryK H Teoh, R D Weisel, J Ivanov, et al.Thrombosis Research. Supplement|January 1, 1990
Suppression of plasminogen activator inhibitor 1 release by fibrin from human umbilical vein endothelial cellsH Fukao, S Ueshima, N Tanaka, et al.Thrombosis Research. Supplement|January 1, 1983
The relationship between dose, pharmacokinetics, plasma-concentrations and antithrombotic effects of nafazatromE Philipp, W Ritter, K PatzschkeThrombosis Research. Supplement|January 1, 1983
The physiological significance of the endoendothelial fibrin lining (EEFL) as the critical interface in the 'vessel-blood organ' and the importance of in vivo 'fibrinogenin formation' in health and diseaseA L CopleyThrombosis Research. Supplement|January 1, 1991
Laboratory monitoring of the clinical effects of low molecular weight heparinsJ M Walenga, D Hoppensteadt, J FareedThrombosis Research. Supplement|January 1, 1990
New developments in thrombolytic therapyD C Collen, H K GoldPageof 7